Back to XTX Topco Ltd XTX Topco Ltd

REGNREGN
Showing 7 of 20 quarters

Position history for XTX Topco LtdXTX Topco Ltd's holdings in REGENERON PHARMACEUTICALS

XTX Topco Ltd holds 30,522 shares of REGN (REGENERON PHARMACEUTICALS), worth $19M as of 2026-Q2. The position was increased (+9468.0% shares). REGN represents 0.2% of XTX Topco Ltd's portfolio.

Current Value

$19M

Current Shares

30,522

Total Value Change

+$18.2M

Total Shares Change

+29,716

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
30,522
+9468.0%
$19M0.2%$623.54
55
2026-Q1
New
319
-
$246,4720.0%$766.66
32
2025-Q3
Exited
0
-100.0%
$00.0%$560.05
0
2025-Q2
Increased
15,305
+320.7%
$8M0.3%$519.56
53
2025-Q1
Increased
3,638
+74.9%
$2.3M0.1%$634.66
47
2024-Q4
Increased
2,080
+158.1%
$1.5M0.1%$698.71
49
2024-Q3
Decreased
806
-23.8%
$847,2990.1%$1,036.94
0

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used